Hepatitis C and HIV coinfection in central region of Argentina: prevalence, genotype characterization and risk factors.
BACKGROUND
This is the first study reporting the epidemiological and molecular characterization of HCV/HIV coinfection in the central region of Argentina.


METHODS
Cross-sectional, epidemiological study (2003-2004).


METHODS
multivariate logistic regression analysis.


RESULTS
The incidence of HCV/HIV coinfection was 12.3%. HCV genotype 1 was the most prevalent (73%). Intravenous drug use was the main independent risk factor for acquiring HCV infection. However, an alternative route (sexual) for viral transmission was suggested.


CONCLUSIONS
These results underscore the potential public health impact of HCV/HIV coinfection in our region.
Ré
Viviana
V
Instituto de Virología Dr. J. M. Vanella, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba. Argentina.
Gallego
Sandra
S
Farías
Adrián
A
Barbás
Gabriela
G
Kremer
Luis
L
Díaz
M Pilar
MP
Contigiani
Marta
M
D000280:Administration, Inhalation; D000328:Adult; D001118:Argentina / Q000453:epidemiology; D001803:Blood Transfusion / Q000706:statistics & numerical data; D003042:Cocaine / Q000008:administration & dosage; D019970:Cocaine-Related Disorders / Q000453:epidemiology; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D005838:Genotype; D015658:HIV Infections / Q000453:epidemiology*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D016174:Hepacivirus / Q000235:genetics / Q000302:isolation & purification; D006526:Hepatitis C / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood; D012307:Risk Factors; D012309:Risk-Taking; D012725:Sexual Behavior / Q000706:statistics & numerical data; D015819:Substance Abuse, Intravenous / Q000453:epidemiology; D013653:Tattooing / Q000009:adverse effects; D065227:Transfusion Reaction
D012367:RNA, Viral; D003042:Cocaine